E. Barreiro Portela (Barcelona, Spain), S. Elborn (Belfast (Belfast), United Kingdom), D. Visca (Tradate, Italy), S. Bazan-Socha (Kraków, Poland)
Osteoporosis and its relation with severity of COPD and steroids use G. Chawla (Jodhpur, India), V. Sharma (Jodhpur, India), S. Jain (Jaipur, India), V. Joshi (Jaipur, India), R. Niwas (Jodhpur, India)
|   |
Bone demineralization in Chronic Obstructive Pulmonary Disease: is there an impact? H. Zaibi (tunis, Tunisia), M. Ferchichi (tunis, Tunisia), S. Mazeoui (tunis, Tunisia), A. Jarrar (tunis, Tunisia), N. Guediri (tunis, Tunisia), R. Hmissi (tunis, Tunisia), J. Ben Ammar (tunis, Tunisia), B. Thahri (tunis, Tunisia), H. Aouina (tunis, Tunisia)
|   |
Assessment of nutritional status of patients with COPD in the hospital T. Zielonka (Warsaw, Poland), M. Hadzik-Blaszczyk (Warsaw, Poland), A. Korzeniewska (Warsaw, Poland), K. Zycinska (Warsaw, Poland)
|  |
Main predictors and correlations of COPD-induced sarcopenia. A. Suleymanova (Moscow, Russian Federation), I. Baranova (Moscow, Russian Federation)
|   |
Vitamin D negatively correlates with blood eosinophilia in stable adult asthmatics V. Carriero (Orbassano, Italy), M. Bullone (Orbassano, Italy), F. Bertolini (Orbassano, Italy), F. Ricciardolo (Orbassano, Italy)
|  |
Nutritional intake and habitual food consumption of patients with COPD in relation to fat-free mass index A. Hedhli Ep Cherni (tunis, Tunisia), S. Ben Khaled (tunis, Tunisia), S. Cheikhrouhou (tunis, Tunisia), S. Toujani (tunis, Tunisia), Y. Ouahchi (tunis, Tunisia), M. Mjid (tunis, Tunisia), S. Merai (tunis, Tunisia)
|  |
Nutrition status and mortality rate during 5-years follow-up in patients with COPD. E. Voláková (Olomouc, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), M. Svoboda (Brno, Czech Republic), M. Plutinsky (Brno, Czech Republic), K. Brat (Brno, Czech Republic), B. Novotna (Praha, Czech Republic), P. Ppopelkova (Ostrava, Czech Republic), P. Musilova (Jihlava, Czech Republic), J. Lnenicka (Praha, Czech Republic), L. Heribanova (Praha, Czech Republic), Z. Liptakova (Ceske Budejovice, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), P. Voglova (Mlada Boleslav, Czech Republic), P. Safranek (Plzen, Czech Republic), R. Simek (Zlin, Czech Republic), L. Nevoranek (Hradec Kralove, Czech Republic), M. Kopecky (Hradec Kralove, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), K. Neumannova (Olomouc, Czech Republic), M. Skrobackova (Brno, Czech Republic), V. Koblizek (Hradec Kralove, Czech Republic)
|  |
Do people with COPD with different BODE index scores present differences in food intake? E. Cipulo Ramos (Presidente Prudente, Brazil), J. Uzeloto (Presidente Prudente, Brazil), F. Lima (Presidente Prudente, Brazil), I. Silva (Presidente Prudente, Brazil), D. Ramos (Presidente Prudente, Brazil), V. Cavalheri (Perth, Australia)
|   |
COPD patients with skeletal muscle dysfunction VS patients without impairment of skeletal muscle. Comparing features of COPD and life quality. V. Poberezhets (Vinnytsia, Ukraine), Y. Mostovoy (Vinnytsia, Ukraine), A. Demchuk (Vinnytsia, Ukraine)
|   |
Impact of Sarcopenia and Malnutrition on disease severity, nutritional variables and inflammatory parameters in COPD patients F. de Blasio (Turin, Italy), D. Dassetto (Turin, Italy), R. Ambrosanio (Turin, Italy), L. Riberi (Turin, Italy), A. Rella (Turin, Italy), C. Bucca (Turin, Italy)
|  |
Under nutrition is common in patients admitted to hospital with exacerbations of COPD B. Sriram (Southport, Australia), M. Chore (Southport, Australia), A. Marshall (Southport, Australia)
|   |
Nutritional status and physical activity in patients with COPD, and factors associated with malnutrition Z. Matkovic (Zagreb, Croatia), D. Cvetko (Zagreb, Croatia), D. Rahelic (Zagreb, Croatia), C. Esquinas (Barcelona, Spain), M. Žarak (Zagreb, Croatia), M. Miravitlles (Barcelona, Spain), N. Tudoric (Zagreb, Croatia)
|   |
Reduced number of subcutaneous adipocytes and metabolic disorders in patients with pulmonary emphysema. T. Tsuji (Tokyo, Japan), K. Imai (Tokyo, Japan), R. Kikuchi (Tokyo, Japan), K. Furukawa (Ibaraki, Japan), K. Toriyama (Tokyo, Japan), M. Ishiwari (Tokyo, Japan), C. Yajima (Tokyo, Japan), J. Kawagoe (Tokyo, Japan), Y. Togashi (Tokyo, Japan), H. Nakamura (Ibaraki, Japan), K. Yamaguchi (Tokyo, Japan), K. Aoshiba (Ibaraki, Japan), S. Abe (Tokyo, Japan)
|  |
Association of serum bilirubin and clinical outcomes in COPD J. Jung (Seoul, Republic of Korea), A. Leem (Seoul, Republic of Korea), Y. Kim (Seoul, Republic of Korea), J. Shin (Seoul, Republic of Korea), Y. Oh (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), K. Study Group (Seoul, Republic of Korea)
|   |
Chronic liver diseases in COPD patients in primary care. E. Klester (Barnaul, Russian Federation), K. Klester (Barnaul, Russian Federation), V. Elykomov (Barnaul, Russian Federation), A. Berdyugina (Barnaul, Russian Federation), I. Belova (Barnaul, Russian Federation), A. Zharikov (Barnaul, Russian Federation)
|  |
The burden of obesity for asthmatic patients. S. Campos Silva (Lisboa, Portugal), N. Caires (Lisboa, Portugal), M. Emiliano (Lisboa, Portugal), R. Gerardo (Lisboa, Portugal), I. Duarte (Lisboa, Portugal), L. Semedo (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal)
|  |
Glucose tolerance and mobilization of neutrophils in smokers with and without chronic obstructive pulmonary disease. N. Pournaras (Stockholm, Sweden), A. Andersson (Gothenburg, Sweden), M. Kovach (Stockholm, Sweden), K. Ganguly (Stockholm, Sweden), M. Padra (Gothenburg, Sweden), H. Asgeirsdottir (Gothenburg, Sweden), K. Che (Stockholm, Sweden), B. Levänen (Stockholm, Sweden), S. Lindén (Gothenburg, Sweden), P. Jansson (Gothenburg, Sweden), I. Qvarfordt (Gothenburg, Sweden), A. Lindén (Stockholm, Sweden)
|   |
Effect of vaccination of pneumococcal infection on the course of chronic obstructive pulmonary disease in combination with diabetes mellitus E. Blinova (Chelyabinsk, Russian Federation), G. Ignatova (Chelyabinsk, Russian Federation), V. Antonov (Chelyabinsk, Russian Federation)
|   |
Diabetes and chronic obstructive pulmonary disease F. Nadia (Sidi bel abbes, Algeria), B. Yamina (Sidi bel abbes, Algeria), T. Abdessamed (Sidi bel abbes, Algeria)
|   |
Association between bronchial reactivity and diabetes type 2 G. Strazda (Riga, Latvia), N. Jurka (Riga, Latvia), O. Madaja (Riga, Latvia), A. Ozola (Riga, Latvia), I. Taivans (Riga, Latvia)
|  |